Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
2,047,125
-
Shares change
-
+726,360
-
Total reported value, excl. options
-
$20,049,463
-
Value change
-
+$7,527,325
-
Put/Call ratio
-
75.6%
-
Number of buys
-
22
-
Number of sells
-
-10
-
Price
-
$9.77
Significant Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q1 2025
45 filings reported holding NVCT - Nuvectis Pharma, Inc. - COM as of Q1 2025.
Nuvectis Pharma, Inc. - COM (NVCT) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,047,125 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (467,419 shares), BALDWIN WEALTH PARTNERS LLC/MA (358,461 shares), IRIDIAN ASSET MANAGEMENT LLC/CT (253,972 shares), GEODE CAPITAL MANAGEMENT, LLC (135,333 shares), MILLENNIUM MANAGEMENT LLC (121,101 shares), UBS Group AG (111,520 shares), BlackRock, Inc. (68,484 shares), FORBES J M & CO LLP (59,000 shares), GOLDMAN SACHS GROUP INC (45,608 shares), and JANE STREET GROUP, LLC (42,299 shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.